Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic and Therapeutic Implications of Cell Division Cycle 20 Homolog in Breast Cancer

15 Jul 2024

Abstract excerpt

Cell division cycle 20 homolog (CDC20) is a well-known regulator of cell cycle progression. Abnormal expression of CDC20 leads to mitotic defects, which play a significant role in cancer development. In breast cancer (BC), CDC20 has been identified as a biomarker that has been linked to poor patient outcomes. In this study, we investigated the association of CDC20 with BC prognosis and immune cell infiltration by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Breast Cancer Therapies
Share to Cancer-related Molecular Pathways
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39061186
DOI: 10.3390/cancers16142546

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic and Therapeutic Implications of Cell Division Cycle 20 Homolog in Breast CancerPMID 39061186Read ↗

Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validationSemantic proximity Read ↗

MDM2-P53 Signaling Pathway-Mediated Upregulation of CDC20 Promotes Progression of Human Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignanciesSemantic proximity Read ↗

Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast CancerSemantic proximity Read ↗

Identification of cell division cycle 20 as a candidate biomarker and potential therapeutic target in bladder cancer using bioinformatics analysisSemantic proximity Read ↗

Key Genes and Prognostic Analysis in HER2+ Breast CancerSemantic proximity Read ↗

CDCA8, a mitosis-related gene, as a prospective pan-cancer biomarker: implications for survival prognosis and oncogenic immunologySemantic proximity Read ↗

Roles of the CDCA gene family in breast carcinomaSemantic proximity Read ↗

Differential gene expression analysis unravels key genes associated with breast cancer proliferationSemantic proximity Read ↗

Selected Ideal Natural Ligand Against TNBC by Inhibiting CDC20, Using Bioinformatics and Molecular BiologySemantic proximity Read ↗

Gene expression profiles analysis identifies a novel two-gene signature to predict overall survival in diffuse large B-cell lymphomaSemantic proximity Read ↗

CLEC10A is A Prognostic Biomarker and is Correlated with Immune Infiltrates in Breast CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.